The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: Occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers

Familial Cancer

Volumn 3, Issue 1, 2004, Pages 11-14

  Gal, Inbar ^a   Gershoni Baruch, Ruth ^b   Haber, Daniel ^c   Dagan, Efrat ^b   Eisenberg Barzilai, Shlomit ^a   Zidan, Jamal ^d   Friedman, Eitan ^a,e  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Rebecca Sieff Government Hospital   (Israel)

^e TEL AVIV UNIVERSITY   (Israel)

Author keywords

BRCA1 2; Founder mutations; Genetic isolate; High risk non Ashkenazim; Shared haplotype

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BIODIVERSITY; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC LINKAGE; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH RISK POPULATION; HUMAN; JEW; MAJOR CLINICAL STUDY; NORTH AFRICA; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; BREAST TUMOR; COHORT ANALYSIS; COMPARATIVE STUDY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; ISRAEL; MIDDLE AGED; MOLECULAR GENETICS; MUTATION; NEGRO; NUCLEOTIDE SEQUENCE; PEDIGREE; RISK ASSESSMENT;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GERM-LINE MUTATION; HAPLOTYPES; HETEROZYGOTE; HUMANS; ISRAEL; JEWS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PEDIGREE; POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 3142682640     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:FAME.0000026837.32470.b4     Document Type: Article

References (28)

1. Hall JM, Lee MK, Newman B et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-9.
2. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
3. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
4. BICdatabase. Retrieved from http://www.nhgri.nih.gov/Intramural_research/ Lab_transfer/Bic/Member/index.html on 15 January 2004.
5. Abeliovich D, Kaduri L, Lerer I et al. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early onset breast cancer patients among Ashkenazi women. Am J Hum Genet 1997; 60: 505-14.
6. Szabo CI, King MC. Population genetics of BRCA1 and BRCA2. Am J Hum Genet 1997; 60: 1013-20.
7. Struewing JP, Abeliovitch D, Peretz T et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995; 11: 198-200.
8. Odduoux C, Struewing JP, Clayton CM et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996; 14: 188-90.
9. Hartge P, Struewing JP, Wacholder S et al. The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 1999; 64: 963-70.
10. Modan B, Hartge P, Hirsh-Yechezhel G et al. Parity, oral contraceptives, and the risk of ovarian cancer among carriers of a BRCA1 and BRCA2 mutation. N Engl J Med 2001; 345: 235-40.
11. Berman DB, Wagner-Costalas J, Schultz DC et al. Two distinct origins of a common mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 1996; 58: 1166-76.
12. Neuhausen SL, Mazoyer S, Friedman L et al. Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet 1996; 58: 271-80.
13. Bruchim Bar-Sade R, Theodor L, Gak E et al. Could the 185delAG BRCA1 mutation be an ancient Jewish mutation? Eur J Hum Genet 1997; 5: 413-6.
14. Neuhausen SL, Godwin AK, Gershoni-Baruch R et al. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet 1998; 62: 1381-8.
15. Ministry of health. Cancer in Israel: trends in cancer incidence and mortality in Israel 1970-1995. Israel Cancer registry 1998; publication #207.
16. Bruchim Bar-Sade R, Kruglikova A, Modan B et al. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the Diaspora and is not limited to Ashkenazim. Hum Mol Genet 1998; 7: 801-6.
17. Theodor L, Bruchim Bar-Sade R, Kruglikova A et al. An identical novel mutation in BRCA1 and a common haplotype in Jewish non-Ashkenazi patients with familial ovarian cancer. Br J Can 1998; 77: 1880-3.
18. Shiri-Sverdlov R, Gershoni Baruch R, Ichezkel-Hirsch G et al. The Tyr978x BRCA1 mutation in non-Ashkenazi Jews: occurrence in high risk families, general population and unselected ovarian cancer patients. Commun Genet 2001; 4: 50-5.
19. Risch HA, McLaughlin JR, Cole DE et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001; 68: 700-10.
20. Lerer I, Wang T, Peretz T et al. The 8765delAG mutation in BRCA2 is common among Jews of Yemenite extraction. Am J Hum Genet 1998; 63: 272-4.
21. Manning AP, Abeliovich D, Ghadirian P et al. Haplotype analysis of BRCA2 8765delAG mutation carriers in French Canadian and Yemenite Jewish hereditary breast cancer families. Hum Hered 2001; 52: 116-20.
22. Pisano M, Cossu A, Persico I et al. Identification of a founder BRCA2 mutation in Sardinia. Br J Cancer 2000; 82: 553-9.
23. Palmieri G, Palomba G, Cossu A et al. BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling. Ann Oncol 2002; 13: 1899-907.
24. Shiri-Sverdlov R, Oefner P, Green L et al. Mutational analysis of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast cancer. Hum Mutat 2000; 16: 491-501.
25. FitzGerald MG, MacDonald DJ, Krainer M et al. Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer. N Engl J Med 1996; 334: 143-9.
26. Lynch HT, Watson P, Tinley S et al. An update on DNA-based BRCA1/BRCA2 genetic counselling in hereditary breast cancer. Cancer Genet Cytogenet 1999; 109: 91-8.
27. Rohlf EM, Learning WG, Friedman KJ et al. Direct detection of mutations in the breast and ovarian cancer susceptibility gene BRCA1 by PCR-mediated site-directed mutagenesis. Clin Chem 1997; 43: 24-9.
28. Barkardottir RB, Sarantaus L, Arason A et al. Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families. Eur J Hum Genet 2001; 9: 773-9.